{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:48Z","timestamp":1786984848825,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Disease","doi-asserted-by":"publisher","award":["81Z0710105"],"award-info":[{"award-number":["81Z0710105"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.atherosclerosis.2025.120593","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T15:59:36Z","timestamp":1763827176000},"page":"120593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Heparin decreases serum sphingosine-1-phosphate levels in patients with vascular diseases"],"prefix":"10.1016","volume":"412","author":[{"given":"Yi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"von Lucadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Geissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus M.","family":"Grewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Wegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Oetjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Sebastian","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Larena-Avellaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3597-6276","authenticated-orcid":false,"given":"Edzard","family":"Schwedhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120593_bib1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120593_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/molecules22030344","article-title":"Sphingosine 1-Phosphate receptor 1 signaling in Mammalian cells","volume":"22","author":"Pyne","year":"2017","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00018-018-2984-8","article-title":"The role of dihydrosphingolipids in disease","volume":"76","author":"Magaye","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000362992","article-title":"Sphingosine 1-phosphate in blood: function, metabolism, and fate","volume":"34","author":"Thuy","year":"2014","journal-title":"Cell Physiol Biochem"},{"issue":"Pt 3","key":"10.1016\/j.atherosclerosis.2025.120593_bib5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3520809","article-title":"Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions","volume":"352","author":"Murata","year":"2000","journal-title":"Biochem J"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2025.120593_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810278","article-title":"Platelet-Derived S1P and its relevance for the communication with immune cells in multiple human diseases","volume":"23","author":"Tolksdorf","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib7","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1055\/s-0040-1701205","article-title":"Determinants of Serum- and Plasma Sphingosine-1-Phosphate concentrations in a healthy study group","volume":"4","author":"Daum","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104793","article-title":"Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology","volume":"156","author":"Jozefczuk","year":"2020","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120593_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","author":"Liu","year":"2000","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2015.03.006","article-title":"Sphingosine 1-phosphate signaling at the blood-brain barrier","volume":"21","author":"Prager","year":"2015","journal-title":"Trends Mol Med"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120593_bib12","first-page":"1871","article-title":"Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice","volume":"119","author":"Camerer","year":"2009","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yexcr.2015.08.013","article-title":"Sphingosine 1-phosphate induced synthesis of glycocalyx on endothelial cells","volume":"339","author":"Zeng","year":"2015","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120593_bib14","doi-asserted-by":"crossref","first-page":"H250","DOI":"10.1152\/ajpheart.00372.2015","article-title":"Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction","volume":"310","author":"Zhang","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120593_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186116","article-title":"Regeneration of glycocalyx by heparan sulfate and sphingosine 1-phosphate restores inter-endothelial communication","volume":"12","author":"Mensah","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/me.2014-1388","article-title":"Inhibition of sphingosine kinase 1 ameliorates angiotensin II-Induced hypertension and inhibits transmembrane calcium entry via store-operated calcium channel","volume":"29","author":"Wilson","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","article-title":"Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs","volume":"30","author":"Cyster","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-physiol-021014-071635","article-title":"Vascular and immunobiology of the circulatory sphingosine 1-Phosphate gradient","volume":"79","author":"Yanagida","year":"2017","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120593_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/biom13050818","article-title":"Sphingosine-1-Phosphate signaling in cardiovascular diseases","volume":"13","author":"Wang","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2015.03.020","article-title":"SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-\/-) mice on high cholesterol diet","volume":"240","author":"Pot\u00ec","year":"2015","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120593_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063360","article-title":"Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice","volume":"8","author":"Bot","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120593_bib22","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1161\/STROKEAHA.120.033414","article-title":"Serum Sphingosine-1-Phosphate levels are associated with severity and outcome in patients with cerebral ischemia","volume":"52","author":"Schwedhelm","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3389\/fneur.2020.00985","article-title":"Serum sphingosine 1-Phosphate (S1P): a novel diagnostic biomarker in early acute ischemic stroke","volume":"11","author":"Liu","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-8703(03)00118-2","article-title":"Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate","volume":"146","author":"Deutschman","year":"2003","journal-title":"Am Heart J"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2025.120593_bib25","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.113.002659","article-title":"\u03b21-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy","volume":"128","author":"Cannavo","year":"2013","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120593_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168302","article-title":"Serum-Sphingosine-1-Phosphate concentrations are inversely associated with atherosclerotic diseases in humans","volume":"11","author":"Soltau","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.29271\/jcpsp.2022.06.697","article-title":"Changes in serum copeptin and sphingosine 1-Phosphate in patients with restenosis after stent implantation of symptomatic intracranial artery stenosis","volume":"32","author":"Jiao","year":"2022","journal-title":"J Coll Physician Surg Pak"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120593_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120593_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","author":"Barnett","year":"1991","journal-title":"N Engl J Med"},{"issue":"117","key":"10.1016\/j.atherosclerosis.2025.120593_bib30","doi-asserted-by":"crossref","DOI":"10.3791\/54755","article-title":"Reproducible arterial denudation injury by infrarenal abdominal aortic clamping in a murine model","author":"Shirali","year":"2016","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120593_bib31","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.CIR.88.3.1215","article-title":"Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration","volume":"88","author":"Rogers","year":"1993","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120593_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.CIR.89.2.770","article-title":"Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis","volume":"89","author":"Edelman","year":"1994","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120593_bib33","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1161\/01.CIR.91.12.2972","article-title":"Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation","volume":"91","author":"Geary","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120593_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/138945008783755601","article-title":"Intimal hyperplasia in murine models","volume":"9","author":"Hui","year":"2008","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120593_bib35","first-page":"379","article-title":"Serum sphingosine 1 phosphate levels in patients with and without coronary collateral circulation","volume":"34","author":"K\u0131z\u0131ltun\u00e7","year":"2018","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2022.03.020","article-title":"Sphingosine-1-phosphate and vascular disease in the general population","volume":"350","author":"Rotheudt","year":"2022","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120593_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/intimm\/dxz037","article-title":"Sphingosine 1-phosphate and inflammation","volume":"31","author":"Obinata","year":"2019","journal-title":"Int Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-511X-12-20","article-title":"Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration","volume":"12","author":"Ono","year":"2013","journal-title":"Lipids Health Dis"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120593_bib39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1194\/jlr.R059543","article-title":"Sources, metabolism, and regulation of circulating sphingosine-1-phosphate","volume":"56","author":"Ksi\u0105\u017cek","year":"2015","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120593_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41569-024-01023-z","article-title":"Targeting immune cell recruitment in atherosclerosis","volume":"21","author":"D\u00f6ring","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120593_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120593_bib42","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1074\/jbc.M110.171819","article-title":"Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking","volume":"286","author":"Allende","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055255","article-title":"Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism","volume":"8","author":"Finley","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120593_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1165\/rcmb.2005-0126OC","article-title":"Neutrophil sphingosine 1-phosphate and lysophosphatidic acid receptors in pneumonia","volume":"34","author":"Rahaman","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120593_bib45","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.4049\/jimmunol.1301791","article-title":"Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes","volume":"193","author":"Gorlino","year":"2014","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120593_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.14715\/cmb\/2024.70.9.25","article-title":"The role of NETosis in enhancing of atherosclerosis","volume":"70","author":"Blagov","year":"2024","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120593_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41419-020-2582-1","article-title":"Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling","volume":"11","author":"Zhao","year":"2020","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120593_bib48","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archsurg.141.11.1132","article-title":"Cell response to surgery","volume":"141","author":"Ni Choileain","year":"2006","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/ijms23010193","article-title":"Fibrinogen and atherosclerotic cardiovascular diseases-review of the literature and clinical studies","volume":"23","author":"Surma","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib50","first-page":"1","article-title":"Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb\/IIIa complex","volume":"72","author":"Calvete","year":"1994","journal-title":"Thromb Haemost"},{"issue":"210","key":"10.1016\/j.atherosclerosis.2025.120593_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-29423-5_3","article-title":"Platelet signaling","author":"Stalker","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120593_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jphs.2016.05.010","article-title":"Cellular function and signaling pathways of vascular smooth muscle cells modulated by sphingosine 1-phosphate","volume":"132","author":"Machida","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761475","article-title":"Dynamics of vascular protective and immune supportive Sphingosine-1-Phosphate during cardiac surgery","volume":"12","author":"Greiwe","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120593_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/cvr\/cvt112","article-title":"Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells","volume":"99","author":"B\u00f6hm","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120593_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.721200","article-title":"Bivalirudin Attenuates thrombin-induced endothelial hyperpermeability via S1P\/S1PR2 category: original articles","volume":"12","author":"Ye","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120593_bib56","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1538-7836.2011.04194.x","article-title":"Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation","volume":"9","author":"Ulrych","year":"2011","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120593_bib57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.119.315099","article-title":"Rivaroxaban reduces arterial thrombosis by inhibition of FXa-Driven platelet activation via protease activated Receptor-1","volume":"126","author":"Petzold","year":"2020","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib58","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0741-5214(91)90055-Y","article-title":"Prevention of stenosis after vascular reconstruction: pharmaco-logic control of intimal hyperplasia--a review","volume":"13","author":"Clowes","year":"1991","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib59","first-page":"442","article-title":"Heparin-derived oligosaccharide inhibits vascular intimal hyperplasia in balloon-injured carotid artery","volume":"15","author":"Liu","year":"2017","journal-title":"Chin J Nat Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib60","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1525-1594.2009.00748.x","article-title":"Heparin coating of small-caliber decellularized xenografts reduces macrophage infiltration and intimal hyperplasia","volume":"33","author":"Cai","year":"2009","journal-title":"Artif Organs"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120593_bib61","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jvs.2010.11.048","article-title":"Low molecular weight (LMW) heparin inhibits injury-induced femoral artery remodeling in mouse via upregulating CD44 expression","volume":"53","author":"Zhao","year":"2011","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120593_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.RES.0000111805.09592.D8","article-title":"Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells","volume":"94","author":"Rauch","year":"2004","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120593_bib63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.RES.87.2.92","article-title":"Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor","volume":"87","author":"Kalmes","year":"2000","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120593_bib64","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0735-1097(95)00277-4","article-title":"The Subcutaneous Heparin and Angioplasty Restenosis prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome","volume":"26","author":"Brack","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120593_bib65","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1067\/mhj.2000.106614","article-title":"Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia","volume":"139","author":"Wilensky","year":"2000","journal-title":"Am Heart J"},{"issue":"6S","key":"10.1016\/j.atherosclerosis.2025.120593_bib66","doi-asserted-by":"crossref","first-page":"201S","DOI":"10.1016\/j.jvs.2018.02.053","article-title":"Sphingosine-1-phosphate receptor 1 regulates neointimal growth in a humanized model for restenosis","volume":"68","author":"Braetz","year":"2018","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120593_bib67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M21-0717","article-title":"Risk for recurrent venous thromboembolism and bleeding with Apixaban compared with rivaroxaban: an analysis of real-world data","volume":"175","author":"Dawwas","year":"2022","journal-title":"Ann Intern Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:25:20Z","timestamp":1781270720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025014911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":67,"alternative-id":["S0021915025014911"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120593","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin decreases serum sphingosine-1-phosphate levels in patients with vascular diseases","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120593"}}